dronabinol oral / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dronabinol oral / Generic mfg.
2018-000014-38: A Phase IIa Study to Determine the Safety, Tolerability and Efficacy of a daily oral dose of THX-110 in Adult Patients with Tourette Syndrome (TS)

Not yet recruiting
2
60
Europe
THX-110 [Dronabinol], THX-110 [PEA (Palmitoylethanolamide)], Capsule, soft, Tablet, Dronabinol Capsules, USP
Therapix Biosciences Ltd., Therapix Biosciences Ltd.
Tourette Syndrome, Neuropsychiatric disorder characterized by multiple motor or vocal tics., Diseases [C] - Nervous System Diseases [C10]
 
 
2021-000305-24: Evaluating the effects of a novel drug on THC effects

Ongoing
2
100
Europe
ANEB001, NAMISOL®, ANEB001, Capsule, soft, Tablet
Anebulo pharmaceuticals, Inc., Anebulo pharmaceuticals, Inc.
THC intoxication, THC overdose, Not possible to specify
 
 
NCT05272865: Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC

Not yet recruiting
1/2
334
RoW
Pharmacokinetic and pharmacodynamic profile of THC oral formulations with Dronabinol as comparator, Administration of different Cannabis oral formulations with THC as compared with Active comparator (DRONABINOL)
LaSanta S A S
Nausea Post Chemotherapy, Vomiting, Cancer Pain, Cancer Related Pain, Neoplasms
02/24
10/24

Download Options